DHR vs MRVL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Marvell Technology, Inc. · Technology
$258.95
-11.4% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MRVL |
| Current Price |
$221.12 |
$258.95 |
| Fair Value Estimate |
$286.52 |
$229.46 |
| Upside to Fair Value |
+29.6%
|
-11.4%
|
| Market Cap |
$155.4B |
$226.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
48.0x
|
| Price / Sales |
6.2x
|
24.0x
|
| Price / FCF |
28.5x
|
134.3x
|
| Revenue Growth YoY |
+5.5%
|
+36.5%
|
| Gross Margin |
58.5%
|
51.4%
|
| Operating Margin |
20.4%
|
16.7%
|
| Return on Equity |
7.7%
|
16.2%
|
| Dividend Yield |
0.65% |
0.09% |
| FCF Yield |
3.51%
|
0.74%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Marvell Technology is a data infrastructure semiconductor specialist that designs custom AI accelerators, electro-optics DSPs, ethernet switching, storage controllers and interconnect silicon for hyperscale data centers, communications and carrier markets, employing roughly 7,480 people under CEO Matthew J. Murphy. Business quality is genuinely high on the demand side: revenue grew 36.5% year ove…
Accumulation Zones
| Metric |
DHR |
MRVL |
| Zone Low |
$214.89 |
$172.09 |
| Zone High |
$243.54 |
$195.04 |
| In Buy Zone? |
Yes
|
No
|